NL1032065A1 - Preparaat voor de preventie en behandeling van cardiovasculaire stoornissen. - Google Patents

Preparaat voor de preventie en behandeling van cardiovasculaire stoornissen.

Info

Publication number
NL1032065A1
NL1032065A1 NL1032065A NL1032065A NL1032065A1 NL 1032065 A1 NL1032065 A1 NL 1032065A1 NL 1032065 A NL1032065 A NL 1032065A NL 1032065 A NL1032065 A NL 1032065A NL 1032065 A1 NL1032065 A1 NL 1032065A1
Authority
NL
Netherlands
Prior art keywords
prevention
preparation
treatment
cardiovascular disorders
cardiovascular
Prior art date
Application number
NL1032065A
Other languages
English (en)
Other versions
NL1032065C2 (nl
Inventor
Wen-Ying Chen
Yi-Chung Chiang
Ling-Hui Cheng Chiang
Frank Chiahung Mao
Original Assignee
Maxluck Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxluck Biotechnology Corp filed Critical Maxluck Biotechnology Corp
Publication of NL1032065A1 publication Critical patent/NL1032065A1/nl
Application granted granted Critical
Publication of NL1032065C2 publication Critical patent/NL1032065C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyridine Compounds (AREA)
NL1032065A 2005-07-05 2006-06-27 Preparaat voor de preventie en behandeling van cardiovasculaire stoornissen. NL1032065C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW94122677 2005-07-05
TW094122677A TWI276442B (en) 2005-07-05 2005-07-05 Composition of controlling and preventing heart disease

Publications (2)

Publication Number Publication Date
NL1032065A1 true NL1032065A1 (nl) 2007-01-08
NL1032065C2 NL1032065C2 (nl) 2007-03-09

Family

ID=36292943

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1032065A NL1032065C2 (nl) 2005-07-05 2006-06-27 Preparaat voor de preventie en behandeling van cardiovasculaire stoornissen.

Country Status (13)

Country Link
US (1) US20070010426A1 (nl)
JP (1) JP2007016012A (nl)
KR (1) KR20070005494A (nl)
AU (1) AU2006201157B2 (nl)
BR (1) BRPI0601290A (nl)
CH (1) CH698459B1 (nl)
DE (1) DE102006012263B4 (nl)
FR (1) FR2888750B1 (nl)
GB (1) GB2428007B (nl)
IT (1) ITMI20060882A1 (nl)
MY (1) MY177085A (nl)
NL (1) NL1032065C2 (nl)
TW (1) TWI276442B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI454221B (en) * 2008-07-14 2014-10-01 Composition and method for inhibiting formation of body fat
US8815310B2 (en) * 2011-01-10 2014-08-26 Morteza Naghavi Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
US9319249B2 (en) * 2014-08-27 2016-04-19 eTopus Technology Inc. Receiver for high speed communication channel
US12219981B1 (en) * 2024-05-22 2025-02-11 Phoenix Creative Nutraceuticals, LLC Methods and compositions to assist and support the formation of red blood cells and hemoglobin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234001A (en) 1961-11-29 1966-02-08 Pacific Adhesives Company Inc Pesticidal composition and method
US4923855A (en) 1983-07-08 1990-05-08 The William Seroy Group Synthetic GTF chromium material and process therefor
US6261606B1 (en) * 1999-09-14 2001-07-17 Natural Compounds, Ltd. Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions
TW490305B (en) * 1999-11-25 2002-06-11 Ling-Huei Cheng Trivalent chromium complex compound for controlling diabetes
TW471951B (en) 2000-04-11 2002-01-11 Ling-Huei Cheng Thivalent chromium milk product and method for producing the same
CN1114618C (zh) * 2000-05-19 2003-07-16 程伶辉 三价铬复合物、其乳制品及其制造方法
CN1185258C (zh) 2000-05-19 2005-01-19 程伶辉 三价铬复合物及其应用
JP3633852B2 (ja) 2000-06-06 2005-03-30 伶輝 程 三価クロム複合物、その乳製品およびその製造方法
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin
AU2003291206A1 (en) * 2002-12-04 2004-06-23 Agennix Incorporated Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
TW200605902A (en) * 2004-08-05 2006-02-16 Maxluck Biotechnology Corp Composition for lowering blood lipid

Also Published As

Publication number Publication date
FR2888750B1 (fr) 2011-03-04
KR20070005494A (ko) 2007-01-10
DE102006012263A1 (de) 2007-01-18
FR2888750A1 (fr) 2007-01-26
GB2428007A (en) 2007-01-17
DE102006012263B4 (de) 2020-06-18
MY177085A (en) 2020-09-04
CH698459B1 (it) 2009-08-14
BRPI0601290A (pt) 2007-03-06
NL1032065C2 (nl) 2007-03-09
TW200701987A (en) 2007-01-16
GB2428007B (en) 2010-06-02
AU2006201157B2 (en) 2007-12-13
US20070010426A1 (en) 2007-01-11
TWI276442B (en) 2007-03-21
AU2006201157A1 (en) 2007-01-25
ITMI20060882A1 (it) 2007-01-06
GB0605387D0 (en) 2006-04-26
JP2007016012A (ja) 2007-01-25

Similar Documents

Publication Publication Date Title
EP1853295A4 (en) METHOD AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISEASES
EP1940441A4 (en) COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
ZA200801706B (en) Methods and compositions for the prevention and treatment of kidney disease
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
WO2006119295A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
WO2006124748A3 (en) Multicyclic compounds and methods of their use
ZA200802762B (en) Pharmaceutical compositions for the treatment of inner ear disorders
ZA200800452B (en) Methods and compositions for the prevention and treatment of kidney disease
EP2007385A4 (en) CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
IL191537A0 (en) Methods and compositions for the treatment of gastrointestinal disorders
NL1028087A1 (nl) Sulfonamiderivaten voor de behandeling van ziekten.
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
IL189009A0 (en) Methods and compositions for the treatment of neuropathies and related disorders
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
NL1033562A1 (nl) Tetrahydropyridoazepine-8-onen en verwante verbindingen voor de behandeling van schizofrenie.
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
NL1030418A1 (nl) Azabenzoxazolen voor de behandeling van CZS-stoornissen.
ITRM20050446A1 (it) Uso di stilbeni idrossilati e glucosidati per la prevenzione ed il trattamento di patologie oculari.
EP1874130A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING NURSE DISEASES
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
WO2006135694A3 (en) Uii-modulating compounds and their use
NL1032065A1 (nl) Preparaat voor de preventie en behandeling van cardiovasculaire stoornissen.
IL191887A0 (en) Method for the diagnosis and treatment of cardiovascular diseases
NL1030417A1 (nl) Azabenzoxazolen voor de behandeling van aandoeningen van het CZS.

Legal Events

Date Code Title Description
AD1B A search report has been drawn up
PD2B A search report has been drawn up
MM Lapsed because of non-payment of the annual fee

Effective date: 20230701